News
Closure of Conceptia Fertility Clinic due to COVID-19 measures
The Atlantic Cancer Research Institute (ACRI) is announcing the immediate closure of its Conceptia Fertility Clinic due to directives from the Canadian Fertility and Andrology Society in response to the COVID-19 threat.
Effective immediately Conceptia will suspend all new consultations and procedures for patients. The clinic will maintain a minimum staff to ensure follow-up consultations and phone calls from existing patients who are in treatment. Embryologist’s expertise will be maintained to protect gametes and embryos in storage.
ACRI is in communication with the Regional Health Authorities about temporary transfer of nurses and staff to assist them during this crisis. ACRI has also communicated with authorities about offering its expertise and infrastructure in molecular testing if required.
"The safety of our staff and patients is our top priority. We want to reassure staff and clients that this measure is temporary and that we hope that activities can resume as soon as possible". Craig Ferguson, Clinical Director of Conceptia.
About Conceptia
Conceptia was founded in 2000 and is the only “full-service” fertility treatment center in New Brunswick and is the only private non for profit fertility Clinic in Canada. This organization is a leading fertility clinic in the country with many years of success above national average, focused entirely on patient-specific treatment strategies and welfare. Conceptia employs innovative and advanced techniques in conjunction with a professional and courteous staff in order to help reach goal of pregnancy in a compassionate, discreet, secure and comfortable setting.
About the Atlantic Cancer Research Institute (ACRI)
The Atlantic Cancer Research Institute is a private, not-for-profit research organisation created in 1998 and located at the Dr. Georges-L.-Dumont University Hospital Centre in Moncton, NB, Canada. Unique to the region and operating a modern biomedical research laboratory, this entrepreneurial team is striving to innovate by accelerating its understanding of cancer, thus paving the way to better diagnosis, more accurate patient stratification and drug discovery.
"This is a very difficult period and we are disappointed that we have to suspend this very important service to families. We also regret the hardship this will cause our staff and their families and hope that we will return to normal activities soon. In the meantime, our talented staff of nurses and receptionists may be able to help our health system deal with this pandemic. " Dr. Rodney Ouellette, President and Scientific Director at ACRI.
